EIM
FOLD

Essex Investment Management’s Amicus Therapeutics FOLD Stock Holding History

Essex Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-231,214
Closed -$2.18M – 312
2024
Q4 		$2.18M Sell
231,214
-37,529
-14% -$390K 0.39% 108
2024
Q3 		$2.87M Buy
268,743
+743
+0.3% +$8.09K 0.5% 83
2024
Q2 		$2.66M Buy
+268,000
New +$2.75M 0.5% 75
2021
Q1 		– Sell
-156,676
Closed -$3.62M – 474
2020
Q4 		$3.62M Sell
156,676
-27,266
-15% -$558K 0.45% 67
2020
Q3 		$2.6M Sell
183,942
-57,692
-24% -$841K 0.37% 73
2020
Q2 		$3.64M Buy
+241,634
New +$2.94M 0.6% 36
2018
Q4 		– Sell
-118,789
Closed -$1.44M – 496
2018
Q3 		$1.44M Sell
118,789
-2,112
-2% -$29.5K 0.17% 180
2018
Q2 		$1.89M Hold
120,901
– – 0.24% 124
2018
Q1 		$1.82M Sell
120,901
-4,480
-4% -$68.2K 0.24% 124
2017
Q4 		$1.8M Sell
125,381
-35,508
-22% -$488K 0.24% 130
2017
Q3 		$2.43M Buy
160,889
+21,474
+15% +$284K 0.33% 84
2017
Q2 		$1.4M Buy
+139,415
New +$1.12M 0.2% 166

Other funds holding FOLD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Essex Investment Management's FOLD Position: Q1 2025 in Review

Essex Investment Management sold out of Amicus Therapeutics (FOLD) in Q1 2025, closing a stake of 231,214 shares — an estimated $2.18M sold.

Essex Investment Management first reported a position in FOLD in Q2 2017 and held it in 12 quarters. The position peaked at $3.64M in Q2 2020. 286 funds tracked by Wall St. Rank hold FOLD as of Q1 2025.

  • Essex Investment Management reported no remaining Amicus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Essex Investment Management sold 231,214 Amicus Therapeutics shares in Q1 2025, an estimated $2.18M.
  • Essex Investment Management first reported a position in Amicus Therapeutics in Q2 2017 and held it in 12 quarters.
  • Essex Investment Management's Amicus Therapeutics position peaked at $3.64M in Q2 2020.
  • 286 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2025.

Based on Essex Investment Management's 13F filing for Q1 2025, filed 7 May 2025.